PHILADELPHIA (WPVI) -- It's the only authorized treatment that can help keep people with COVID-19 out of the hospital, but hundreds-of-thousands of doses aren't being used. The effectiveness of ...

U.S. Navy Petty Officer 3rd Class Andre May, a Sailor with Expeditionary Medical Facility-M and a native of Mount Vernon, N.Y., checks a patient’s blood pressure at Baton Rouge General Mid City campus ...

Monoclonal antibody treatments are saving lives from COVID-19 and helps keep patients out of Triangle hospitals. Doctors are infusing newly diagnosed COVID-19 patients with antibodies that have been ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

NEW YORK (WABC) -- Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the omicron variant of the coronavirus ...

More than a year after the FDA yanked away authorization from Evusheld, a monoclonal antibody treatment for COVID-19, the agency granted emergency use authorization to a new COVID-19 preventive drug ...

The pause affects Sotrovimab from GlaxoSmithKline. The federal government is sharply pulling back on one of the monoclonal antibody treatments authorized for COVID-19, pausing its use across eight ...

COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health ...

In the ongoing battle against COVID-19, the United States has leaned heavily on vaccines as its primary weapon. While vaccination has been a cornerstone of the country’s public health strategy, it's ...

Data supporting antibodies is limited compared to that for authorized vaccines. Despite more than 187 million Americans being fully vaccinated against COVID-19 and data and attestations from ...